Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Relay Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RLAY.
You can purchase shares of Relay Therapeutics (NASDAQ:RLAY) through any online brokerage.
Other companies in Relay Therapeutics’s space includes: Precigen (NASDAQ:PGEN), Upstream Bio (NASDAQ:UPB), Celcuity (NASDAQ:CELC), Immatics (NASDAQ:IMTX) and Sage Therapeutics (NASDAQ:SAGE).
Relay Therapeutics has a consensus price target of $20.30.
The stock price for Relay Therapeutics (NASDAQ: RLAY) is $2.1 last updated April 4, 2025 at 7:56 PM EDT.
There are no upcoming dividends for Relay Therapeutics.
Relay Therapeutics’s Q1 earnings are confirmed for Thursday, May 1, 2025.
There is no upcoming split for Relay Therapeutics.
Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.